Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. - sprookjes - yvandenbroek - TriplyDB

Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections.

Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections.

http://www.wikidata.org/entity/Q35219959

about

The perils of PCR: can we accurately 'correct' antimalarial trials?Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing.Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial The suitability of P. falciparum merozoite surface proteins 1 and 2 as genetic markers for in vivo drug trials in Yemen Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine Population genetics of Trypanosoma evansi from camel in the Sudan.Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.Genetic diversity among Plasmodium falciparum field isolates in Pakistan measured with PCR genotyping of the merozoite surface protein 1 and 2.A cohort study of Plasmodium falciparum infection dynamics in Western Kenya Highlands.Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren.Treatment with coartem (artemether-lumefantrine) in Papua New Guinea Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan children Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants Innate immunity induced by Plasmodium liver infection inhibits malaria reinfections.Relevance of undetectably rare resistant malaria parasites in treatment failure: experimental evidence from Plasmodium chabaudi.Evidence for both innate and acquired mechanisms of protection from Plasmodium falciparum in children with sickle cell trait.Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology Robust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping.THE REAL McCOIL: A method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites.Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment Local population structure of Plasmodium: impact on malaria control and elimination.Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.A general SNP-based molecular barcode for Plasmodium falciparum identification and tracking.Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.Effects of Plasmodium falciparum mixed infections on in vitro antimalarial drug tests and genotyping.Large-scale genotyping and genetic mapping in Plasmodium parasites.Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.Parasite dynamics in the peripheral blood and the placenta during pregnancy-associated malaria infection Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis Overlap Extension Barcoding for the Next Generation Sequencing and Genotyping of Plasmodium falciparum in Individual Patients in Western Kenya.Gel versus capillary electrophoresis genotyping for categorizing treatment outcomes in two anti-malarial trials in Uganda.Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children.Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials

P2860

Q24615919-2E45F954-3CC1-4218-A5D9-B1320FB7C73B Q24633707-DF222259-D6A8-473B-8453-7FC53C3BE9BE Q28469217-9BA9F417-EDD9-4E4E-A054-FDAB062DE963 Q28534510-4D48C71E-199A-44B1-803F-D4BCD70613EC Q28542034-8408BA1E-19B3-4A4D-A5FE-52B617CE0525 Q31017879-10360279-457A-4877-9040-772ACD44546E Q33342827-950AD16C-1725-48EE-8D92-0AD06E4AFD0B Q33489551-FBFC5584-A7AE-4F13-B82E-AD7D094CDE7A Q33590165-91462211-37EE-44AB-9E98-DDB846F44AC8 Q33702770-C2260692-2284-4D61-8633-B9E8CD8E11CC Q33728165-938B2598-C280-4DF7-A543-BE1F00FE30F3 Q33749688-C55D28A0-D1F5-4895-B132-078254189E01 Q33826359-0E7BDB1C-0867-457A-AB66-65BD3FE96528 Q33947834-9D74D34F-0337-429C-8166-F47E78A5E923 Q33992235-FA5EEE79-1EE0-4CBA-A191-5E3542A8A582 Q34922694-567C4366-9D38-4EBB-B81C-D2568C5A5D83 Q35004867-17BD9BBF-2709-41E0-9D36-0412A3D8888B Q35055212-FD27469B-AE43-460A-A333-69ADAC52C7FC Q35098216-740E6FAB-5400-4491-B40C-547E25078207 Q35692528-09B3524D-4B6B-424C-AE6E-8E69EAD61925 Q35909680-453BA6FC-4D0F-42EB-9E37-C870729C35EE Q35994181-0F1C0F25-5B2A-4121-A1AC-A3DD0E03CC1F Q36075776-696B25DC-C22A-447C-B3DE-38F6ACE5B7EF Q36260900-E0395CCE-043B-4E0E-BE99-9D5CDAEC3BC9 Q36373020-7639D2B4-D6E0-48B1-AF63-5E346524E09F Q36513390-25F7BCA6-E9D8-4D39-A1F4-3DA3F09517C8 Q36644765-DA47A058-D8C9-4CC4-8580-8F9C0C2307C1 Q36812874-2DBDD319-40E7-458C-B6E2-34F25D5FF6C5 Q36976565-F72CDA12-A1C7-4341-B579-43348B11C56E Q37096787-4D30578B-57F6-4D38-8E28-E2ED60D9EB30 Q37186635-0F5D3DDE-0DFD-44D9-A70F-2E78F5C53925 Q37208414-F75A9443-1648-4FCB-990B-82E7250857DB Q37272095-CF508097-4BAC-4CB3-97C3-3FE1C04210B3 Q37272665-8F6898DF-46BF-4817-93E2-47B2BEFFB505 Q37279764-59128181-C0C7-422C-B337-1F09B0C463C5 Q37350167-4D9015BD-F66C-4744-A03B-44A827C3D312 Q37602150-33C891A1-5B2B-49C1-A98F-5AC6E6104DFF Q38873068-8D5F1771-8766-4E52-A4C3-1ABDE98E71B0 Q40210481-F43BC8F0-43D5-494D-801B-E9327CD1C09B Q41868814-E2EA6A09-1B6C-44BE-8FF7-AC7C27DCA946

P2860

Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections.

http://www.wikidata.org/entity/Q35219959

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Validation of microsatellite m ...... smodium falciparum infections.

@ast

Validation of microsatellite m ...... smodium falciparum infections.

@en

type

label

Validation of microsatellite m ...... smodium falciparum infections.

@ast

Validation of microsatellite m ...... smodium falciparum infections.

@en

prefLabel

Validation of microsatellite m ...... smodium falciparum infections.

@ast

Validation of microsatellite m ...... smodium falciparum infections.

@en

P1433

Q35219959-C4189B22-4819-4593-AC33-7B21513E4924

P1476

Q35219959-2555210E-9D09-4293-AD8B-45016F7E2E17

P2093

Q35219959-29950077-BFF6-49EC-A983-DD1B4DE36B0C

Q35219959-2A5C69D7-7554-42C3-AD2A-A3AA2722ED8F

Q35219959-9EF9DD6F-C6FD-4025-A088-2FE52D90925B

Q35219959-B6700A98-395F-4B60-9917-B04DBF50CDDB

Q35219959-CF8901F3-1ED4-474F-AED4-71CD04EFBCE0

Q35219959-E478C2AA-CA90-41BF-9779-093BCD7D8B92

P2860

Q35219959-0297E4C8-C7A3-4D4F-BCA9-60B84AFA3200

Q35219959-08EC722A-DD32-47B6-A69A-24CC8D9D7FD8

Q35219959-0B5B17B3-8CE1-4EA3-BA06-B23FD890FDEF

Q35219959-0EA46A3E-06C1-4597-AD91-84E4A8B15EE5

Q35219959-15D53993-70DF-4973-BB4D-86703336044F

Q35219959-1B18654C-E028-4883-A03F-4EFF4DC8A563

Q35219959-1EF4F7B7-80E8-470E-BD46-1510A6E37374

Q35219959-2AA1B560-819F-4DD9-9EA1-D15F005BC2A4

Q35219959-467FA505-19F1-4D69-9DC6-6A7AFAC6BF21

Q35219959-554DFF41-C61A-44B4-AAE4-62F5A302CD8E

P304

Q35219959-275E8044-FCCF-4613-9673-4D15F5B4E6DD

P31

Q35219959-02BA469D-CD49-4CF7-9617-75CB12B0F47C

P356

Q35219959-5DCE319D-5D6F-4402-B253-976413387513

P407

Q35219959-9C43A9EF-3B03-45A4-BC46-753ED270D6CE

P433

Q35219959-2F93E2B1-2AF0-4F0D-9F78-7204D1FE1F6C

P478

Q35219959-C051BA2A-2783-4673-975C-CC39B4D004B9

P50

Q35219959-2B5DF0CA-8586-4C0B-AC2D-169E69F4EF1D

P577

Q35219959-DBB6EFBC-A3FD-4B83-BEAE-1328F75186C7

P698

Q35219959-EF46189A-FA63-494D-AABF-D30C6F2B1C67

P921

Q35219959-746F2230-7A0E-47D4-995B-36439CE89DD8

Q35219959-C3596355-5060-44E9-A107-CF947E58C032

P932

Q35219959-1B305C41-682C-4DDE-846C-068302FA6BB9

P356

AJTMH.2006.75.836

P1433

American Journal of Tropical Medicine and Hygiene

P1476

Validation of microsatellite m ...... asmodium falciparum infections

@en

P2093

Alissa Myrick

http://www.w3.org/2001/XMLSchema#string

Christian Dokomajilar

http://www.w3.org/2001/XMLSchema#string

Elaine J Carlson

http://www.w3.org/2001/XMLSchema#string

Grant Dorsey

http://www.w3.org/2001/XMLSchema#string

Jonathan M Woo

http://www.w3.org/2001/XMLSchema#string

Philip J Rosenthal

http://www.w3.org/2001/XMLSchema#string

P2860

Primer3 on the WWW for general users and for biologist programmers

Heteroduplexes in mixed-template amplifications: formation, consequence and elimination by 'reconditioning PCR'

Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats.

Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy.

Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion.

Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections.

The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment.

Taq DNA polymerase slippage mutation rates measured by PCR and quasi-likelihood analysis: (CA/GT)n and (A/T)n microsatellites

Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.

P304

836-842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4269/AJTMH.2006.75.836

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Bryan Greenhouse

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17123974

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

1697796

http://www.w3.org/2001/XMLSchema#string